Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats

People who expose to mixture of crude oil products had been reported to show several diseased-symptoms including hypertension, liver failure and chronic complications. The drugs for treating multiple-complex diseases are scarcely available. Cashew nut snack is known to check multiple diseases and ea...

Full description

Saved in:
Bibliographic Details
Main Authors: J.K. Akintunde, A.O. Osifeso, O.E. Eteng, F.C. Thomas
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Medicine in Omics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590124923000111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850177585707745280
author J.K. Akintunde
A.O. Osifeso
O.E. Eteng
F.C. Thomas
author_facet J.K. Akintunde
A.O. Osifeso
O.E. Eteng
F.C. Thomas
author_sort J.K. Akintunde
collection DOAJ
description People who expose to mixture of crude oil products had been reported to show several diseased-symptoms including hypertension, liver failure and chronic complications. The drugs for treating multiple-complex diseases are scarcely available. Cashew nut snack is known to check multiple diseases and easily accessible by indigenous-patients with no lethal-effects. Here, we examined the corrective-measures of roasted-cashew-nut (RCN) against hypertension co-morbidity with liver-failure in male rats on exposure to mixture of fractionated-petroleum-products (MFPP). Seventy (70) male-albino-rats (n = 10) were randomly exposed to MFPP for 14 days. Group 1: control rats were given basal-diet. Group 2 was given basal diet + 0.2 ml/day-MFPP. Group 3 was given 0.2 ml/day-MFPP + 50 mg/kg Atenolol. Group 4 was given 0.2 ml/day-MFPP + 10 % RCN. Group 5 was given 0.2 ml/day-MFPP + 20 % RCN. Group 6 was given 10 % RCN. Group 7 was given 20 % RCN. We found that high activities of liver-arginase, MAO-A, AChE, ADA, PDE-51 and ATP-hydrolytic-enzymes with low-bioavailability of NO-level on exposure to MFPP implicated liver-failure and hypertension. Also, up-regulation of HIF-1, p53, TNF-α, and MCP-1 with reduced-level of 1L-10 were connected to liver-failure and hypertension. However, post-treatment with 10 % RCN and 20 % RCN for 14-days corrected liver-failure and hypertension by inhibiting liver-arginase, MAO-A, AChE, ADA, PDE-51 and ATP-hydrolytic-enzymes. Also, liver-failure characterized by vascular-congestion and sinusoidal-dilation on exposure to 0.2 ml/day-MFPP was reversed by 10 % RCN and 20 % RCN via down-regulation of liver HIF-1, p53, TNF-α, MCP-1 with increased 1L-10. We conclude that 10 % RCN and 20 % RCN may be an innovative-snacks against hepatocellular damage co-morbidity with hypertension.
format Article
id doaj-art-71c9490d29cb476cbf3fd29ecd7f7a5f
institution OA Journals
issn 2590-1249
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Medicine in Omics
spelling doaj-art-71c9490d29cb476cbf3fd29ecd7f7a5f2025-08-20T02:18:57ZengElsevierMedicine in Omics2590-12492024-12-011210003010.1016/j.meomic.2023.100030Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male ratsJ.K. Akintunde0A.O. Osifeso1O.E. Eteng2F.C. Thomas3Molecular Toxicology and Biomedical Research Group, Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Nigeria; Corresponding author.Molecular Toxicology and Biomedical Research Group, Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, NigeriaMolecular Toxicology and Biomedical Research Group, Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, NigeriaDepartment of Physiology and Biochemistry, College of Veterinary Medicine, Federal University of Agriculture, Abeokuta, NigeriaPeople who expose to mixture of crude oil products had been reported to show several diseased-symptoms including hypertension, liver failure and chronic complications. The drugs for treating multiple-complex diseases are scarcely available. Cashew nut snack is known to check multiple diseases and easily accessible by indigenous-patients with no lethal-effects. Here, we examined the corrective-measures of roasted-cashew-nut (RCN) against hypertension co-morbidity with liver-failure in male rats on exposure to mixture of fractionated-petroleum-products (MFPP). Seventy (70) male-albino-rats (n = 10) were randomly exposed to MFPP for 14 days. Group 1: control rats were given basal-diet. Group 2 was given basal diet + 0.2 ml/day-MFPP. Group 3 was given 0.2 ml/day-MFPP + 50 mg/kg Atenolol. Group 4 was given 0.2 ml/day-MFPP + 10 % RCN. Group 5 was given 0.2 ml/day-MFPP + 20 % RCN. Group 6 was given 10 % RCN. Group 7 was given 20 % RCN. We found that high activities of liver-arginase, MAO-A, AChE, ADA, PDE-51 and ATP-hydrolytic-enzymes with low-bioavailability of NO-level on exposure to MFPP implicated liver-failure and hypertension. Also, up-regulation of HIF-1, p53, TNF-α, and MCP-1 with reduced-level of 1L-10 were connected to liver-failure and hypertension. However, post-treatment with 10 % RCN and 20 % RCN for 14-days corrected liver-failure and hypertension by inhibiting liver-arginase, MAO-A, AChE, ADA, PDE-51 and ATP-hydrolytic-enzymes. Also, liver-failure characterized by vascular-congestion and sinusoidal-dilation on exposure to 0.2 ml/day-MFPP was reversed by 10 % RCN and 20 % RCN via down-regulation of liver HIF-1, p53, TNF-α, MCP-1 with increased 1L-10. We conclude that 10 % RCN and 20 % RCN may be an innovative-snacks against hepatocellular damage co-morbidity with hypertension.http://www.sciencedirect.com/science/article/pii/S2590124923000111Roasted cashew nutMixtureFractionated petroleum productsHypertensionLiver damageRats
spellingShingle J.K. Akintunde
A.O. Osifeso
O.E. Eteng
F.C. Thomas
Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats
Medicine in Omics
Roasted cashew nut
Mixture
Fractionated petroleum products
Hypertension
Liver damage
Rats
title Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats
title_full Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats
title_fullStr Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats
title_full_unstemmed Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats
title_short Roasted cashew nut supplement inhibits MCP-1 and inflammatory mediators to correct hypertension related liver failure induced by mixed-fractionated petroleum products via NOS-cAMP-PKA signaling pathway in male rats
title_sort roasted cashew nut supplement inhibits mcp 1 and inflammatory mediators to correct hypertension related liver failure induced by mixed fractionated petroleum products via nos camp pka signaling pathway in male rats
topic Roasted cashew nut
Mixture
Fractionated petroleum products
Hypertension
Liver damage
Rats
url http://www.sciencedirect.com/science/article/pii/S2590124923000111
work_keys_str_mv AT jkakintunde roastedcashewnutsupplementinhibitsmcp1andinflammatorymediatorstocorrecthypertensionrelatedliverfailureinducedbymixedfractionatedpetroleumproductsvianoscamppkasignalingpathwayinmalerats
AT aoosifeso roastedcashewnutsupplementinhibitsmcp1andinflammatorymediatorstocorrecthypertensionrelatedliverfailureinducedbymixedfractionatedpetroleumproductsvianoscamppkasignalingpathwayinmalerats
AT oeeteng roastedcashewnutsupplementinhibitsmcp1andinflammatorymediatorstocorrecthypertensionrelatedliverfailureinducedbymixedfractionatedpetroleumproductsvianoscamppkasignalingpathwayinmalerats
AT fcthomas roastedcashewnutsupplementinhibitsmcp1andinflammatorymediatorstocorrecthypertensionrelatedliverfailureinducedbymixedfractionatedpetroleumproductsvianoscamppkasignalingpathwayinmalerats